Maximus, Inc. (MMS) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 0.67%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | 0.67% | Share-based compensation / revenue. Period ending 2026-06-30. $35.13M ÷ $5.25B × 100 ≈ 0.67% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | 5.25B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 35.13M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 578.99M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $5.25B | $35.13M | $578.99M | (m) | (m) | 0.67% | (m) | (m) |
| 2026-03-31 | (m) | $5.32B | $38.52M | $583.23M | (m) | (m) | 0.72% | (m) | (m) |
| 2025-12-31 | (m) | $5.37B | $41.25M | $587.71M | (m) | (m) | 0.77% | (m) | (m) |
| 2025-09-30 | (m) | $5.43B | $41.18M | $528.29M | (m) | (m) | 0.76% | (m) | (m) |
| 2025-06-30 | (m) | $5.43B | $38.07M | $517.18M | (m) | (m) | 0.70% | (m) | (m) |
| 2025-03-31 | (m) | $5.40B | $36.80M | $493.25M | (m) | (m) | 0.68% | (m) | (m) |
| 2024-12-31 | (m) | $5.38B | $32.87M | $467.78M | (m) | (m) | 0.61% | (m) | (m) |
| 2024-09-30 | (m) | $5.31B | $35.35M | $488.50M | (m) | (m) | 0.67% | (m) | (m) |
| 2024-06-30 | (m) | $5.25B | $34.89M | $475.87M | (m) | (m) | 0.66% | (m) | (m) |
| 2024-03-31 | (m) | $5.12B | $33.70M | $392.52M | (m) | (m) | 0.66% | (m) | (m) |
| 2023-12-31 | (m) | $4.98B | $34.55M | $327.53M | (m) | (m) | 0.69% | (m) | (m) |
| 2023-09-30 | (m) | $4.90B | $29.52M | $294.79M | (m) | (m) | 0.60% | (m) | (m) |
| 2023-06-30 | (m) | $4.82B | $30.64M | $310.19M | (m) | (m) | 0.64% | (m) | (m) |
| 2023-03-31 | (m) | $4.76B | $29.37M | $306.36M | (m) | (m) | 0.62% | (m) | (m) |
| 2022-12-31 | (m) | $4.73B | $26.63M | $319.15M | (m) | (m) | 0.56% | (m) | (m) |
| 2022-09-30 | (m) | $4.63B | $30.48M | $325.90M | (m) | (m) | 0.66% | (m) | (m) |
| 2022-06-30 | (m) | $4.56B | $29.81M | $279.55M | (m) | (m) | 0.65% | (m) | (m) |
| 2022-03-31 | (m) | $4.68B | $30.13M | $364.59M | (m) | (m) | 0.64% | (m) | (m) |
| 2021-12-31 | (m) | $4.46B | $30.74M | $402.49M | (m) | (m) | 0.69% | (m) | (m) |
| 2021-09-30 | (m) | $4.25B | $28.55M | $408.53M | (m) | (m) | 0.67% | (m) | (m) |
| 2021-06-30 | (m) | $4.07B | $26.97M | $424.88M | $4.54M | (m) | 0.66% | 93.52× | Reported |
| 2021-03-31 | (m) | $3.73B | $25.39M | $372.59M | $2.07M | (m) | 0.68% | 179.82× | Reported |
| 2020-12-31 | (m) | $3.59B | $24.37M | $296.71M | $1.78M | (m) | 0.68% | 166.60× | Reported |
| 2020-09-30 | (m) | $3.46B | $23.71M | $288.28M | $2.06M | (m) | 0.68% | 140.01× | Reported |
| 2020-06-30 | (m) | $3.29B | $23.01M | $281.33M | $1.91M | (m) | 0.70% | 147.45× | Reported |
| 2020-03-31 | (m) | $3.12B | $22.67M | $277.62M | $1.71M | (m) | 0.73% | 162.16× | Reported |
| 2019-12-31 | (m) | $3.04B | $21.20M | $322.11M | $2.82M | (m) | 0.70% | 114.38× | Reported |
| 2019-09-30 | (m) | $2.89B | $20.77M | $317.11M | $2.96M | (m) | 0.72% | 107.24× | Reported |
| 2019-06-30 | (m) | $2.69B | $19.85M | $301.44M | $3.20M | (m) | 0.74% | 94.08× | Reported |
| 2019-03-31 | (m) | $2.56B | $18.82M | $300.42M | $2.87M | (m) | 0.74% | 104.71× | Reported |
| 2018-12-31 | (m) | $2.43B | $19.81M | $289.94M | $1.46M | (m) | 0.81% | 199.00× | Reported |
| 2018-09-30 | (m) | $2.39B | $20.24M | $295.48M | $1.00M | (m) | 0.85% | 295.48× | Reported |
| 2018-06-30 | (m) | $2.45B | $21.26M | $311.17M | $521.00K | (m) | 0.87% | 597.25× | Reported |
| 2018-03-31 | (m) | $2.46B | $22.45M | $310.40M | $894.00K | (m) | 0.91% | 347.21× | Reported |
| 2017-12-31 | (m) | $2.47B | $21.88M | $319.42M | $1.48M | (m) | 0.89% | 215.68× | Reported |
| 2017-09-30 | (m) | $2.45B | $21.36M | $313.51M | $2.16M | (m) | 0.87% | 145.01× | Reported |
| 2017-06-30 | (m) | $2.45B | $20.75M | $317.23M | $2.89M | (m) | 0.85% | 109.62× | Reported |
| 2017-03-31 | (m) | $2.47B | $19.83M | $320.03M | $3.46M | (m) | 0.80% | 92.36× | Reported |
| 2016-12-31 | (m) | $2.45B | $19.31M | $317.59M | $3.99M | (m) | 0.79% | 79.52× | Reported |
| 2016-09-30 | (m) | $2.40B | $18.75M | $286.60M | $4.13M | (m) | 0.78% | 69.33× | Reported |
| 2016-06-30 | (m) | $2.36B | $18.27M | $266.82M | $4.00M | (m) | 0.77% | 66.71× | Reported |
| 2016-03-31 | (m) | $2.31B | $17.95M | $253.28M | $3.66M | (m) | 0.78% | 69.20× | Reported |
| 2015-12-31 | (m) | $2.19B | $17.60M | $237.39M | $2.39M | (m) | 0.80% | 99.45× | Reported |
| 2015-09-30 | (m) | $2.10B | $17.24M | $259.83M | $1.40M | (m) | 0.82% | 185.86× | Reported |
| 2015-06-30 | (m) | $1.96B | $17.25M | $250.11M | (m) | (m) | 0.88% | (m) | (m) |
| 2015-03-31 | (m) | $1.80B | $17.15M | $234.27M | (m) | (m) | 0.95% | (m) | (m) |
| 2014-12-31 | (m) | $1.76B | $17.16M | $237.24M | (m) | (m) | 0.97% | (m) | (m) |
| 2014-09-30 | (m) | $1.70B | $17.28M | $225.31M | (m) | (m) | 1.02% | (m) | (m) |
| 2014-06-30 | (m) | $1.65B | $16.66M | $230.58M | (m) | (m) | 1.01% | (m) | (m) |
| 2014-03-31 | (m) | $1.56B | $16.05M | $219.71M | (m) | (m) | 1.03% | (m) | (m) |
| 2013-12-31 | (m) | $1.45B | $15.16M | $205.50M | (m) | (m) | 1.04% | (m) | (m) |
| 2013-09-30 | (m) | $1.33B | $14.55M | $186.21M | (m) | (m) | 1.09% | (m) | (m) |
| 2013-06-30 | (m) | $1.25B | $13.94M | $169.11M | (m) | (m) | 1.12% | (m) | (m) |
| 2013-03-31 | (m) | $1.18B | $13.51M | $158.03M | (m) | (m) | 1.14% | (m) | (m) |
| 2012-12-31 | (m) | $1.10B | $12.76M | $134.69M | (m) | (m) | 1.16% | (m) | (m) |
| 2012-09-30 | (m) | $1.05B | $12.08M | $127.58M | (m) | (m) | 1.15% | (m) | (m) |
| 2012-06-30 | (m) | $999.51M | $11.39M | $122.44M | (m) | (m) | 1.14% | (m) | (m) |
| 2012-03-31 | (m) | $971.46M | $10.62M | $119.92M | (m) | (m) | 1.09% | (m) | (m) |
| 2011-12-31 | (m) | $955.12M | $10.22M | $122.01M | (m) | (m) | 1.07% | (m) | (m) |
| 2011-09-30 | (m) | $929.63M | $9.48M | $122.40M | (m) | (m) | 1.02% | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-09-30 | (m) | $831.75M | $7.92M | $107.41M | (m) | (m) | 0.95% | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-09-30 | (m) | $720.11M | $7.31M | $88.59M | (m) | (m) | 1.01% | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CBIZ, Inc. (CBZ) | United States | $2.968B | 14.47 |
| TRINET GROUP, INC. (TNET) | United States | $3.008B | 13.00 |
| Shift4 Payments, Inc. (FOUR) | United States | $3.014B | 31.52 |
| Payoneer Global Inc. (PAYO) | United States | $2.419B | 47.94 |
| TIC Solutions, Inc. (TIC) | United States | $1.936B | -15.28 |
| Western Union CO (WU) | United States | $1.878B | 6.06 |
| Sezzle Inc. (SEZL) | United States | $3.695B | 35.75 |
| Concentrix Corp (CNXC) | United States | $1.792B | -1.31 |
| ACV Auctions Inc. (ACVA) | United States | $1.775B | -19.26 |
| Nutex Health Inc. (NUTX) | United States | $1.400B | 6.53 |